Proposed disc zone breakpoints for doripenem for use with the BSAC disc susceptibility testing method

Journal of Antimicrobial Chemotherapy

Volumn 65, Issue 7, 2010, Pages 1547-1548

  Hope, Russell ^a   Pllana, Teresa ^a   Warner, Marina ^a   Livermore, David M ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

Carbapenems; EUCAST; MICs

Indexed keywords

DORIPENEM; ANTIINFECTIVE AGENT; CARBAPENEM DERIVATIVE;

ACINETOBACTER; AGAR DILUTION; ANALYTICAL ERROR; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BETA HEMOLYTIC STREPTOCOCCUS; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED STUDY; DRUG MONITORING; ENTEROBACTERIACEAE; ENTEROCOCCUS; LETTER; MICROBIAL SENSITIVITY TEST; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PSEUDOMONAS; STAPHYLOCOCCUS; STREPTOCOCCUS PNEUMONIAE; BACTERIA; DRUG EFFECTS; EUROPEAN UNION; HUMAN; PROCEDURES;

ANTI-BACTERIAL AGENTS; BACTERIA; CARBAPENEMS; EUROPEAN UNION; HUMANS; MICROBIAL SENSITIVITY TESTS;

EID: 77954223666     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkq144     Document Type: Letter

References (4)

1. European Committee on Antimicrobial Susceptibility Testing (EUCAST). http://www.eucast.org/ (6 October 2009, date last accessed).
2. Andrews JM, for the BSAC Working Party on Susceptibility Testing. BSAC standardized disc susceptibility testing method (version 8). J Antimicrob Chemother 2009; 64: 454-89.
3. BSAC Resistance Surveillance Project. http://www.bsac.org.uk/resistance_surveillance.cfm (6 October 2009, date last accessed).
4. Andrews JM. Determination of minimum inhibitory concentrations. J Antimicrob Chemother 2001; 48 Suppl 1: 5-16.